Genetic referral patterns and outcomes among patients with non-ischemic cardiomyopathy requiring advanced therapies

Patients with advanced heart failure (HF) due to a range of cardiomyopathy (CMP) subtypes often require advanced therapies including left ventricular assist devices (LVADs) or orthotopic heart transplantation (OHT). Nonischemic etiologies underlie roughly half of patients with advanced HF requiring advanced therapies.1,2 Over the last two decades, experts have increasingly recognized the prognostic and therapeutic impact of defining specific CMP endotypes toward the goal of personalized medicine.

Source: Journal of Cardiac Failure - April 5, 2024 Category: Cardiology Authors: Rebecca Castro, Emir Veledar, Leslee Shaw, Donna Mancini, Noah Moss, Veronica Fettig, Amy R. Kontorovich, Anuradha Lala Tags: Research Letter Source Type: research